| Literature DB >> 31616370 |
Huirong Peng1, Xiaochun Liang1, Zhe Long2, Zhao Chen1, Yuting Shi1, Kun Xia3, Li Meng4, Beisha Tang1,3,5,6,7,8,9, Rong Qiu10, Hong Jiang1,3,5,6,11.
Abstract
Background: Spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) is one of the nine polyglutamine (polyQ) diseases and is caused by a CAG repeat expansion within the coding sequence of the ATXN3 gene. Few multimodal imaging analyses of the macro- and micro-structural changes have been performed.Entities:
Keywords: 1HMRS; gray matter; imaging genetics study; spinocerebellar ataxia 3; white matter
Year: 2019 PMID: 31616370 PMCID: PMC6768953 DOI: 10.3389/fneur.2019.01025
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Figure 1Flow-chart of the study. Seventy participants (including 36 SCA3/MJD patients and 34 normal controls) volunteered and were screened for inclusion and exclusion criteria. Five SCA3/MJD patients had to be excluded because they were younger than 18 years old. Three normal controls had to be excluded because they had neurological or psychiatric deficits. Sixty-two participants (including 31 SCA3/MJD patients and 31 normal controls) were enrolled in the study.
Figure 2The anatomically defined ROIs in the 1HMRS images. 1 = MCP; 2 = dentate nucleus; 3 = cerebellar vermis; 4 = cerebellar cortex; 5 = putamen; 6 = thalamus.
Figure 3ROIs of the cerebellar peduncles in the color-coded FA maps. The anatomically defined ROIs of the cerebellar peduncles in the color-coded FA maps (superior row) and their resulting fiber tracts (inferior row). SCP, superior cerebellar peduncle; MCP, middle cerebellar peduncle; ICP, inferior cerebellar peduncle.
Demography and clinical assessments of the controls and SCA/MJD subjects.
| Sex (male/female) | 15/16 | 15/16 |
| Age (year) | 37.53 ± 10.18 | 38.91 ± 7.38 |
| Age of onset (year) | NA | 34.88 ± 6.64 |
| Duration of disease (year) | NA | 4.81 ± 3.63 |
| ICARS total score | NA | 26.81 ± 10.82 |
| CAG trinucleotide repeats length | NA | 71.84 ± 2.61 |
Expressed as mean ± SD. NA, not applicable.
Figure 4Reduced white matter volume in the SCA3/MJD patients. Reduced gray matter volume in the SCA3/MJD patients compared with the controls based on voxel-based morphometry (p < 0.05). The color bar refers to the T-values.
Reduced gray matter volume in the SCA3/MJD patients via the voxel-based morphometry.
| Cerebellum | Right cerebellar culmen | 171,811 | 14.40 | 0 | −51 | −27 |
| Left cerebellar culmen | 12.53 | −13 | −16 | −22 | ||
| Sub lobar | Left Insula | 1,051 | 5.37 | −34 | −23 | 9 |
| Right Insula | 542 | 4.24 | 40 | −5 | 9 | |
| Frontal lobe | Left Inferior frontal gyrus | 337 | 4.56 | −36 | 25 | −19 |
| Right Inferior frontal gyrus | 144 | 4.40 | 22 | 19 | −21 | |
| Left Superior frontal gyrus | 352 | 4.70 | −5 | 52 | 37 | |
The ICARS total scores or CAG was correlated with the gray matter volume in the SCA3/MJD patients.
| ICARS | Left cerebellar culmen | 246 | 4.64 | −5 | 62 | −9 |
| Right pons | 1,215 | 4.02 | 14 | −26 | −40 | |
| Left midbrain | 264 | 3.67 | −2 | −42 | −21 | |
| Left cerebellar lingual | −2 | −42 | −15 | |||
| CAG | Right cerebellar culmen | 215 | 2.89 | 25 | −42 | −22 |
Neurochemistry of the 1HMRS images in the controls and patient group.
| Middle cerebellar peduncle | NAA/Cr | 2.21 ± 0.59 | 1.41 ± 0.44 | |
| Cho/Cr | 1.18 ± 0.29 | 1.10 ± 0.34 | ||
| NAA/Cho | 1.91 ± 0.41 | 1.31 ± 0.36 | ||
| Dentate nucleus | NAA/Cr | 1.32 ± 0.24 | 1.07 ± 0.22 | |
| Cho/Cr | 1.07 ± 0.18 | 1.01 ± 0.20 | ||
| NAA/Cho | 1.25 ± 0.20 | 1.07 ± 0.19 | ||
| Cerebellar vermis | NAA/Cr | 1.22 ± 0.23 | 0.96 ± 0.25 | |
| Cho/Cr | 1.00 ± 0.18 | 0.88 ± 0.23 | ||
| NAA/Cho | 1.24 ± 0.23 | 1.12 ± 0.28 | ||
| Cerebellar cortex | NAA/Cr | 1.17 ± 0.33 | 1.02 ± 0.27 | |
| Cho/Cr | 0.92 ± 0.24 | 0.88 ± 0.23 | ||
| NAA/Cho | 1.31 ± 0.34 | 1.23 ± 0.37 | ||
| Putamen | NAA/Cr | 1.22 ± 0.27 | 1.23 ± 0.34 | |
| Cho/Cr | 0.87 ± 0.30 | 0.95 ± 0.31 | ||
| NAA/Cho | 1.48 ± 0.44 | 1.37 ± 0.43 | ||
| Thalamus | NAA/Cr | 1.68 ± 0.37 | 1.47 ± 0.47 | |
| Cho/Cr | 1.05 ± 0.29 | 0.99 ± 0.34 | ||
| NAA/Cho | 1.63 ± 0.35 | 1.47 ± 0.24 |
After Bonferroni adjustment for multiple testing, p ≤ 0.008 was considered as significant in the correlation analysis (six tests).
NAA, N-acetyl-aspartate; Ch, choline-containing compounds; Cr, creatine and phosphocreatine.
Relationship between 1H-MRS and clinic variable in SCA3/MJD group.
| Middle cerebellar peduncle | NAA/Cr | −0.45 | −0.54 |
| Cho/Cr | −0.27 | −0.0.27 | |
| NAA/Cho | −0.27 | −0.23 | |
| Dentate nucleus | NAA/Cr | −0.50 | −0.57 |
| Cho/Cr | −0.37 | −0.51 | |
| NAA/Cho | −0.003 | 0.06 | |
| Cerebellar vermis | NAA/Cr | −0.28 | −0.34 |
| Cho/Cr | −0.26 | −0.45 | |
| NAA/Cho | 0.01 | 0.14 | |
| Cerebellar cortex | NAA/Cr | 0.01 | −0.12 |
| Cho/Cr | 0.14 | −0.07 | |
| NAA/Cho | 0.05 | −0.06 | |
| Putamen | NAA/Cr | −0.16 | −0.18 |
| Cho/Cr | −0.22 | −0.11 | |
| NAA/Cho | 0.09 | −0.02 | |
| Thalamus | NAA/Cr | −0.18 | 0.04 |
| Cho/Cr | −0.20 | −0.05 | |
| NAA/Cho | −0.02 | 0.01 |
p < 0.001. After Bonferroni adjustment for multiple testing, p ≤ 0.008 was considered as significant in the correlation analysis (six tests).
NAA, N-acetyl-aspartate; Ch, choline-containing compounds; Cr, creatine and phosphocreatine.
Figure 5Tractography of the cerebellar peduncles. Tractography of the cerebellar peduncles in a control (upper row) and a SCA3/MJD patient (lower row).
Reduced fractional anisotropy in the cerebellar peduncles of the SCA3/MJD patients.
| Superior cerebellar peduncle | 0.37 ± 0.02 | 0.28 ± 0.03 |
| Middle cerebellar peduncle | 0.38 ± 0.03 | 0.29 ± 0.03 |
| Inferior cerebellar peduncle | 0.34 ± 0.04 | 0.23 ± 0.03 |
p < 0.0001. After Bonferroni adjustment for multiple testing, p ≤ 0.01 was considered as significant in the correlation analysis (three tests).
Increase mean diffusivity in the cerebellar peduncles of the SCA3/MJD patients.
| Superior cerebellar peduncle | 0.74 ± 0.04 | 0.86 ± 0.07 |
| Middle cerebellar peduncle | 0.69 ± 0.03 | 0.76 ± 0.06 |
| Inferior cerebellar peduncle | 0.75 ± 0.09 | 0.92 ± 0.10 |
p < 0.0001. After Bonferroni adjustment for multiple testing, p ≤ 0.01 was considered as significant in the correlation analysis (three tests).
Relationship between FA and MD and clinic variable in SCA3/MJD group.
| ICARS | −0.64 | 0.56 | −0.42* | 0.44* | −0.60 | 0.34 |
| Duration | −0.68 | 0.63 | −0.53 | 0.43* | −0.69 | 0.32 |
p < 0.001. After Bonferroni adjustment for multiple testing, p ≤ 0.01 was considered as significant in the correlation analysis (three tests).